Holen Sie sich die Stockscreener-App
4.885
1.56%
0.075
Neonc Technologies Holdings Inc Aktie (NTHI) Neueste Nachrichten
WSTPR Catalyst Watch: NeOnc Strengthens Capital Position Ahead of Potentially Transformational Neuro-Oncology Updates - TMX Newsfile
NTHI Q1 2026 Earnings: Wider-than-Expected EPS Loss Amid Pre-Revenue Phase; Stock Rises 5.56%Strong Earnings Momentum - newsline.com
NeOnc Technologies Announces New Series A Preferred Financing - TipRanks
NeOnc Technologies Announces Up To $5 Million Series A Convertible Preferred Private Placement - TradingView
NeOnc Technologies sets up $5M Series A preferred sale | NTHI 8-K Filing - Stock Titan
NeOnc (NTHI) virtual shareholder meeting Aug 14, 2026 — director elections, Plan Amendment - Stock Titan
NTHI Q1 2026 Earnings: EPS Misses as Clinical-Stage Biotech Reports Continued R&D Spend, Stock RisesPositive Surprise Momentum - lwvtexas.org
NeOnc Technologies Holdings, Inc. (NTHI) Stock Price, News, Quote & History - Yahoo! Finance Canada
The Race to Defeat Brain Cancer Could Become One of the Biggest Biotech Stories of the Decade - Nasdaq
NeOnc Technologies Initiated at Buy by Alliance Global Partners - Moomoo
NTHI Q1 2026 Earnings: Wider-than-Expected Loss Reflecting Pre-Revenue R&D StageEarnings Season Preview - newsline.com
NTHI Q1 2026 Earnings: EPS Miss Reflects Pre‑Revenue Biotech’s Rising R&D BurnNegative Surprise Momentum - newsline.com
NeOnc Shares Move Up With Key Brain Cancer Trial Updates Ahead - Bez Kabli
NeonC technologies (NTHI) president buys $153k in stock - Investing.com
NTHI Q1 2026 Earnings: Clinical-Stage Biotech Misses EPS Estimates but Stock Edges HigherConsensus Forecast Report - newsline.com
NeOnc Technologies Emerges as Top Penny Stock After Analysts Issue Buy Ratings - asatunews.co.id
Alliance Global and Maxim Initiate Coverage on NeOnc Technologies - HarianBasis.co
NeOnc Technologies (NTHI) Could Be Targeting A Challenging Market With A Different Strategy - Insider Monkey
NTHI Q1 2026 Earnings: Wider-than-Expected Loss as Pre-Revenue Biotech Continues R&D InvestmentFinal Results - The Legal Advocate
The Next Great AI Revolution May Be Drug Delivery - GlobeNewswire
Analysts Offer Insights on Healthcare Companies: Spectral AI (MDAI), NeOnc Technologies Holdings, Inc. (NTHI) and Innoviva (INVA) - The Globe and Mail
NTHI - Finviz
BTIG Maintains NeOnc Technologies(NTHI.US) With Buy Rating, Maintains Target Price $15 - Moomoo
NeOnc Technologies (NTHI) Slips Nearly 2% as Stock Holds Above Key SupportJurik MA - The Legal Advocate
NeOnc Technologies (NTHI) Edges Lower but Holds Above Key Support as Trading Volume Remains SubduedZero Lag EMA - The Legal Advocate
NeOnc Technologies Holds Ground Near Key Support Amid Biotech Uncertainty (NTHI)Bull Flag - The Legal Advocate
NeOnc Technologies Holdings (NTHI) Holds Near Support as Modest Decline Tests Key LevelFactor Valuation - Newser
NTHI Q1 2026 Earnings: Wider-than-Expected Loss as Pre-Revenue Biotech Focuses on Pipeline Development - newsline.com
NTHI Initiated Coverage by Alliance Global Partners -- Rating Se - GuruFocus
NeOnc Technologies Gains Growing Institutional Support Ahead of Key Brain Cancer Clinical Milestones - The Manila Times
NeOnc Technologies Gains Analyst Favor with Growing Insider and Institutional Interest in CNS Cancer Therapies - Quiver Quantitative
Wall Street firms back brain-cancer biotech as trial data nears - Stock Titan
A. G. P. Initiates NeOnc Technologies(NTHI.US) With Buy Rating, Announces Target Price $13 - Moomoo
NeOnc Technologies Reports Q1 2026 Results: Advancing Phase 2 CNS Cancer Trials and Strengthening Financial Position 1 2 3 - Minichart
NeOnc Provides Business Update and Reports Q1 2026 Financial Results - Sahm
NeOnc Advances Glioma Programs and Strengthens Financial Position - TipRanks
NeOnc Technologies Price Target Announced at $20.00/Share by Maxim Group - Moomoo
NeOnc Technologies (Nasdaq: NTHI) posts Q1 loss, advances NEO212 and NEO100 - Stock Titan
NeOnc Technologies Holdings, Inc. Reports Q1 2026 Financial Results and Advances Key CNS Cancer Clinical Programs - Quiver Quantitative
Cinctive Capital (NTHI) reports 2.48M shares, including 1.06M warrants - Stock Titan
NEONC TECHNOLOGIES HOLDINGS, INC. 1Q 2026: Revenue $0 EPS $(0.38) — 10-Q Summary - TradingView
NeOnc Technologies (NASDAQ: NTHI) burns cash, flags going-concern risk despite $13.1M PIPE - Stock Titan
NeOnc Technologies Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
NeOnc Technologies Holdings, Inc.Common Stock (NQ: NTHI - The Chronicle-Journal
Number of shareholders of NeOnc Technologies Holdings, Inc. – NASDAQ:NTHI - TradingView
Neonc Technologies : NTHI - 24/7 Wall St.
Forget the 242% Biotech Meme. This Brain Cancer Stock Has a $38 Analyst Target and Trades at $6 - Yahoo Finance
NeOnc Technologies (NASDAQ:NTHI) Positioned for Potential Breakthrough in Brain Cancer Treatment Amidst Biotech Market Shift - Quiver Quantitative
A biotech CEO spent $500K+ as a brain cancer trial nears data - Stock Titan
Biotech’s Next Wave May Already be in Motion - marketscreener.com
The quiet strength in NeOnc (NTHI) business model (Surges Ahead) 2026-05-06Day Trade - newser.com
CEO buys $500K+ in brain-cancer biotech with trial data expected - Stock Titan
Where Executives Are Doubling Down on Their Companies’ Fortunes - marketscreener.com
4.93%
0.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):